Institutionelle bei Medimmune

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Putnam Investment Management, Inc. 15,530,656 $444,642,681
FMR Corporation (Fidelity Management & Research Corp) 15,217,085 $435,665,143
BB Biotech Ag 11,218,784 $321,193,785
Barclays Bank Plc 10,979,298 $314,337,301
Jennison Associates LLC 9,715,074 $278,142,568
Price (T.Rowe) Associates 8,930,861 $255,690,550
JP Morgan Chase & Company 7,751,042 $221,912,332
American Express Financial Corp 7,533,755 $215,691,405
Morgan Stanley 5,529,012 $158,295,613
State Street Corporation 5,328,475 $152,554,239

Topliste der investierten Fonds
Fidelity Select Portfolios - Biotechnology 5,232,220 $149,798,458
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 4,480,723 $128,283,099
Fidelity Aggressive Growth Fund 3,947,128 $113,006,274
Putnam New Opportunities Fund 3,238,300 $92,712,529
Putnam Vista Fund 2,711,500 $77,630,245
Fidelity Growth Company Fund 2,362,800 $67,646,964
Vanguard Index 500 Fund 1,769,705 $50,666,654
Price (T.Rowe) Mid Cap Growth Fund 1,700,000 $48,671,000
Putnam Health Sciences Trust 1,532,368 $43,871,695
ING Variable Annuity-Ing Growth & Income Fund 1,432,300 $41,006,749